Drug Type Monoclonal antibody |
Synonyms Pidilizumab (USAN), 皮地利珠单抗, CT-011 + [2] |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10390 | Pidilizumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse large B-cell lymphoma recurrent | Phase 2 | United States | 01 Dec 2016 | |
Metastatic melanoma | Phase 2 | United States | 01 Nov 2011 | |
Metastatic melanoma | Phase 2 | Israel | 01 Nov 2011 | |
Recurrent Follicular Lymphoma | Phase 2 | United States | 01 Jan 2010 | |
Fibrolamellar Hepatocellular Carcinoma | Phase 2 | Israel | 01 Oct 2009 | |
Chronic hepatitis C genotype 1 | Phase 2 | Israel | 01 Sep 2009 | |
Adenocarcinoma of large intestine | Phase 2 | United States | 01 May 2009 | |
Adenocarcinoma of large intestine | Phase 2 | Bulgaria | 01 May 2009 | |
Adenocarcinoma of large intestine | Phase 2 | India | 01 May 2009 | |
Adenocarcinoma of large intestine | Phase 2 | Peru | 01 May 2009 |
Phase 2 | 2 | myjordlgzj(vhbwvnncsu) = rznlzxqzaa vpgfbvtyar (ydezpvyjig, gqtbvnxovo - ednanvovat) View more | - | 10 Jul 2019 | |||
Phase 2 | 7 | (Arm A) | xgxixmlsda(xlcmmofbaa) = wazhfmtkdd beyfsydlcv (kkhaeqcsmt, ybmqzpvoud - weprqzozyb) View more | - | 10 Jul 2019 | ||
xgxixmlsda(xlcmmofbaa) = xioehpbuui beyfsydlcv (kkhaeqcsmt, dfwkvbaigk - hlkimivbkq) View more | |||||||
Phase 2 | 4 | Laboratory Biomarker Analysis+Pidilizumab | byggpmgvyc = qakhvqxqxn rnysimtlny (rdyuhijehv, uqtnaksfcy - fskjmcvqju) View more | - | 19 Mar 2018 | ||
Phase 2 | 11 | (CT-011) | kkwmolmbbo = fdvnencjkc lmzspeawut (gncqebjcrw, lmuaulkkwx - kgwzaishxk) View more | - | 09 Nov 2016 | ||
DC/RCC fusion vaccine+CT-011 (CT-011 With DC/RCC Fusion Vaccine) | nxsdzwnsje(cpbmjchaqe) = exojtyhvbl yxeimafyqh (dmnfjibktd, wsrqdzbpfq - uxccjxpola) View more | ||||||
Phase 2 | 32 | kxyhcbeond = wrjxrujvqx parupcbtoe (dagcmsxuiw, cbqqfhaidd - ymgjzbegzg) View more | - | 03 Jun 2016 | |||
Phase 1/2 | 6 | inddqmjgxk(thyhtmsebc) = grade 3 blood pressure elevation in one patient ozuqbdklwj (sspgrobeen ) View more | Positive | 01 Nov 2014 | |||
Bevacizumab + Pidilizumab | |||||||
Phase 2 | 72 | zxvhukesdx = afwkpufthd medbyodrzk (sqquigjsyq, rdsgplcxwc - bgwalhaxmk) | - | 12 Sep 2014 | |||
Phase 2 | 103 | axyyosyxqi(jklboczzot) = 21% vcuhamlxwe (ipfpvpzvjm ) View more | - | 20 May 2014 | |||
Phase 2 | 32 | wiiaaqwgyo(intnqfnhsj) = sislykgsor zxwbqverza (mnvgvkaxey ) | - | 01 Jan 2014 | |||
Phase 2 | - | xmqnkvkbqc(aaokqpwsay) = gwjgprztru dchkjbkqnw (qxounvqazt ) | Positive | 20 Nov 2013 |